Anti-STAG3L5P-PVRIG2P-PILRB monoclonal antibody

Pre-made anti-STAG3L5P-PVRIG2P-PILRB monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STAG3L5P-PVRIG2P-PILRB/STAG3L5P-PVRIG2P-PILRB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1838-Ab-1/ GM-Tg-hg-IP1838-Ab-2Anti-Human STAG3L5P-PVRIG2P-PILRB monoclonal antibodyHuman
GM-Tg-rg-IP1838-Ab-1/ GM-Tg-rg-IP1838-Ab-2Anti-Rat STAG3L5P-PVRIG2P-PILRB monoclonal antibodyRat
GM-Tg-mg-IP1838-Ab-1/ GM-Tg-mg-IP1838-Ab-2Anti-Mouse STAG3L5P-PVRIG2P-PILRB monoclonal antibodyMouse
GM-Tg-cynog-IP1838-Ab-1/ GM-Tg-cynog-IP1838-Ab-2Anti-Cynomolgus/ Rhesus macaque STAG3L5P-PVRIG2P-PILRB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1838-Ab-1/ GM-Tg-felg-IP1838-Ab-2Anti-Feline STAG3L5P-PVRIG2P-PILRB monoclonal antibodyFeline
GM-Tg-cang-IP1838-Ab-1/ GM-Tg-cang-IP1838-Ab-2Anti-Canine STAG3L5P-PVRIG2P-PILRB monoclonal antibodyCanine
GM-Tg-bovg-IP1838-Ab-1/ GM-Tg-bovg-IP1838-Ab-2Anti-Bovine STAG3L5P-PVRIG2P-PILRB monoclonal antibodyBovine
GM-Tg-equg-IP1838-Ab-1/ GM-Tg-equg-IP1838-Ab-2Anti-Equine STAG3L5P-PVRIG2P-PILRB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1838-Ab-1/ GM-Tg-hg-IP1838-Ab-2; GM-Tg-rg-IP1838-Ab-1/ GM-Tg-rg-IP1838-Ab-2;
GM-Tg-mg-IP1838-Ab-1/ GM-Tg-mg-IP1838-Ab-2; GM-Tg-cynog-IP1838-Ab-1/ GM-Tg-cynog-IP1838-Ab-2;
GM-Tg-felg-IP1838-Ab-1/ GM-Tg-felg-IP1838-Ab-2; GM-Tg-cang-IP1838-Ab-1/ GM-Tg-cang-IP1838-Ab-2;
GM-Tg-bovg-IP1838-Ab-1/ GM-Tg-bovg-IP1838-Ab-2; GM-Tg-equg-IP1838-Ab-1/ GM-Tg-equg-IP1838-Ab-2
Products NameAnti-STAG3L5P-PVRIG2P-PILRB monoclonal antibody
Formatmab
Target NameSTAG3L5P-PVRIG2P-PILRB
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STAG3L5P-PVRIG2P-PILRB monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1838-Ag-1Recombinant multi-species STAG3L5P-PVRIG2P-PILRB/ FDFACT/ LOC101735302-LOC101752334-PILRB protein


    Target information

    Target IDGM-IP1838
    Target NameSTAG3L5P-PVRIG2P-PILRB
    Gene ID101752399
    Gene Symbol and SynonymsFDFACT,LOC101735302-LOC101752334-PILRB,PILRB,STAG3L5P-PVRIG2P-PILRB
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000272752
    Target ClassificationN/A

    The target: STAG3L5P-PVRIG2P-PILRB, gene name: STAG3L5P-PVRIG2P-PILRB, also named as FDFACT, LOC101735302-LOC101752334-PILRB, PILRB. This locus represents naturally occurring readthrough transcription among the neighboring LOC101735302 (stromal antigen 3 pseudogene), LOC101752334 (poliovirus receptor related immunoglobulin domain containing pseudogene) and PILRB (paired immunoglobin-like type 2 receptor beta) genes on chromosome 7. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.